Summary: Genetic ancestry as well as the lived experience of each patient shapes the landscape and effects of somatic alterations in acute myeloid leukemia (AML), determining outcomes. Expanding our knowledge of how these factors affect risk prognostication and care of a diverse patient population will help overcome existing survival disparities, thereby improving our knowledge and care of all patients with AML.
Eisfeld et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: